Unlicensed pharmacies purporting to sell pharmaceutical drugs are thriving despite the efforts by the U.S. Drug Enforcement Administration to stop them.

Through the resolution of issues and the strengthening of shared aims, both nations can access limitless potential and ...

Inmed Pharmaceuticals Inc. ( ($INM) ) has released its Q2 earnings. Here is a breakdown of the information Inmed ...

Elite Pharmaceuticals ( ($ELTP) ) has released its Q3 earnings. Here is a breakdown of the information Elite Pharmaceuticals presented to its ...

Donald Trump's threat to hit trading partners with ‘reciprocal’ tariffs could hit Australian jobs and economic output hard if ...

Doximity reported strong Q3 performance, driven by high pharma client demand. Click here to find out why DOCS stock has been ...

Alberta Health Services (AHS) issued a $28-million prepayment to Edmonton importer MHCare for a pharmaceutical order that ...

Wide-moat GE HealthCare, or GEHC, is a top three global leader in the medical imaging market. It has a firmly established footprint in hospitals and health networks around the world, and it is ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...

Following the earnings announcement, WST stock plummeted 38% due to its disappointing guidance. Over a broader timeframe, its ...

These customized levies, expected to be finalized by April, are designed to rebalance trade relationships and target unfair ...